-
This Treatment Reduces Toxic Protein Levels in ALS Patients
Biogen’s investigational therapy tofersen can significantly reduce toxic SOD1 protein levels in patients with familial ALS, Phase 1/2 trial results show. Read more about this research here.
Are you interested in following this research as it progresses?
Sorry, there were no replies found.
Log in to reply.